Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.7B | 9.5B | 10.3B | 10.6B |
Cost of revenue | 7.1B | 8.7B | 9.1B | 9.1B |
Gross profit | 549M | 750M | 1.2B | 1.4B |
Operating expense | ||||
Research & development | 34M | 39M | 31M | 33M |
Selling general and admin | 401M | 426M | 404M | 407M |
Other operating expenses | — | — | — | — |
Operating income | 114M | 285M | 807M | 970M |
Non operating interest income | ||||
Income | 30M | 36M | 36M | 37M |
Expense | 107M | 116M | 118M | 120M |
Other income expense | 22M | -1.1B | -14M | 287M |
Pretax income | 59M | -878M | 711M | 1.2B |
Tax provision | 36M | -265M | 134M | 249M |
Net income | 177M | -603M | 573M | 924M |
Basic EPS | 0.5 | — | 1.8 | 2.8 |
Diluted EPS | 0.5 | — | 1.8 | 2.8 |
Basic average shares | 324M | — | 325M | 326M |
Diluted average shares | 324M | — | 326M | 326M |
EBITDA | 489M | 580M | 1.2B | 1.7B |
Net income from continuing op. | 177M | -603M | 573M | 924M |
Minority interests | -2M | 5M | -3M | -1M |
Preferred stock dividends | 2M | 13M | -4M | 5M |